Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Li-Ran Ye"'
Publikováno v:
Heliyon, Vol 10, Iss 2, Pp e24534- (2024)
Abstracts: Background: Patients with psoriasis may experience an exacerbation in symptoms following COVID-19 infection. After abandoning 'zero COVID' strategies, China experienced a surge of Omicron infections. Objectives: We aimed to investigate pso
Externí odkaz:
https://doaj.org/article/5a737ac41f6e43adb0508cacd7823d05
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
The skin is the outermost barrier that separates the human body from the external environment. In psoriasis, immune cells reside within or infiltrate the epidermis to form the epidermal (epithelial) immunological microenvironment (EIME) and engage in
Externí odkaz:
https://doaj.org/article/624656b0e66e44f5a43b7b73859ec6ff
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundTreatment for pediatric psoriasis is challenging because of the lack of real-world evidence, especially for biological therapies.ObjectivesThis study evaluated the efficacy and safety of biologics in children with psoriasis based on real-wo
Externí odkaz:
https://doaj.org/article/d8c09fb480f647a2bcaed30cf039f131
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Psoriasis is a chronic multisystem inflammatory disease that affects ~0.1–1.5% of the world population. The classic cutaneous manifestation of psoriasis is scaly erythematous plaques, limited or widely distributed. Moreover, psoriasis could be asso
Externí odkaz:
https://doaj.org/article/5893217defa24e849e0f852fd36f9c66
Publikováno v:
Dermatologic Therapy. 35
Secukinumab is a recombinant, fully human monoclonal anti-IL-17A antibody approved to treat moderate-to-severe psoriasis and psoriatic arthritis. Its effectiveness and safety have been confirmed, but a gradual increase in the secukinumab dosing inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11ee5518cfa43c10fd7668776df051a7
https://doi.org/10.1111/dth.15911
https://doi.org/10.1111/dth.15911
Publikováno v:
Journal of the American Academy of Dermatology. 86:1348-1350
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8447f56e6e1cb71bb3bb01ef87707f42
https://doi.org/10.1016/j.jaad.2021.04.093
https://doi.org/10.1016/j.jaad.2021.04.093
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 8 (2021)
Frontiers in Medicine, Vol 8 (2021)
Psoriasis is a chronic multisystem inflammatory disease that affects ~0.1–1.5% of the world population. The classic cutaneous manifestation of psoriasis is scaly erythematous plaques, limited or widely distributed. Moreover, psoriasis could be asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2432fbf19875cb48203bbc1b09aab7d
https://doi.org/10.3389/fmed.2021.649408
https://doi.org/10.3389/fmed.2021.649408